Joanna Schmidt

808 total citations
8 papers, 60 citations indexed

About

Joanna Schmidt is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Joanna Schmidt has authored 8 papers receiving a total of 60 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 2 papers in Organic Chemistry and 2 papers in Oncology. Recurrent topics in Joanna Schmidt's work include RNA modifications and cancer (3 papers), RNA and protein synthesis mechanisms (3 papers) and RNA Research and Splicing (2 papers). Joanna Schmidt is often cited by papers focused on RNA modifications and cancer (3 papers), RNA and protein synthesis mechanisms (3 papers) and RNA Research and Splicing (2 papers). Joanna Schmidt collaborates with scholars based in United States and China. Joanna Schmidt's co-authors include Tianyuan Zhou, Youngsoo Kim, A. Robert MacLeod, Xiaokun Xiao, Xiaolin Luo, Minji Jo, Noah Post, Stéphanie Klein, Zhengfeng Yin and Thazha P. Prakash and has published in prestigious journals such as Blood, Cancer Research and Molecular Therapy.

In The Last Decade

Joanna Schmidt

8 papers receiving 60 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joanna Schmidt United States	3	48	12	8	8	6	8	60
Georgette Tanner United Kingdom	4	26 0.5×	20 1.7×	6 0.8×	7 0.9×	4 0.7×	8	48
Zvi Cramer United States	6	38 0.8×	8 0.7×	4 0.5×	16 2.0×	3 0.5×	7	61
Yi Bei China	4	61 1.3×	15 1.3×	4 0.5×	7 0.9×	4 0.7×	7	76
Cecilia A. Castellano United States	2	74 1.5×	14 1.2×	6 0.8×	8 1.0×	8 1.3×	4	89
Adil Al Hinai Netherlands	3	41 0.9×	13 1.1×	4 0.5×	5 0.6×	6 1.0×	4	69
Dan A. Landau United States	2	45 0.9×	18 1.5×	4 0.5×	6 0.8×	5 0.8×	2	54
Mahshid Rahmat United States	3	37 0.8×	23 1.9×	8 1.0×	12 1.5×	4 0.7×	8	49
A. Norton United States	2	25 0.5×	10 0.8×	8 1.0×	10 1.3×	17 2.8×	3	38
Charlotte Eaton United States	4	31 0.6×	8 0.7×	6 0.8×	14 1.8×	4 0.7×	8	54
Tripti Shrestha Bhattarai United States	2	34 0.7×	10 0.8×	4 0.5×	10 1.3×	3 0.5×	3	39

Countries citing papers authored by Joanna Schmidt

Since Specialization

Citations

This map shows the geographic impact of Joanna Schmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joanna Schmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joanna Schmidt more than expected).

Fields of papers citing papers by Joanna Schmidt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joanna Schmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joanna Schmidt. The network helps show where Joanna Schmidt may publish in the future.

Co-authorship network of co-authors of Joanna Schmidt

This figure shows the co-authorship network connecting the top 25 collaborators of Joanna Schmidt. A scholar is included among the top collaborators of Joanna Schmidt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joanna Schmidt. Joanna Schmidt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Liu, Arthur, et al.. (2024). Type I MET inhibitors cooperate with PD-1 blockade to promote rejection of hepatocellular carcinoma. Journal for ImmunoTherapy of Cancer. 12(10). e009690–e009690. 2 indexed citations

Kim, Tae‐Won, et al.. (2023). Abstract 450: Preclinical development of FTX-001: first in class inhibitor of the long non-coding RNA MALAT1. Cancer Research. 83(7_Supplement). 450–450. 1 indexed citations

Kim, Youngsoo, Joanna Schmidt, Minji Jo, et al.. (2020). Abstract B09: Selective depletion of YAP1 with next-generation (constrained ethyl-cEt) antisense oligonucleotides results in tumor regression in mouse models of HCC with YAP1 activation. Molecular Cancer Research. 18(8_Supplement). B09–B09. 1 indexed citations

Kim, Youngsoo, Minji Jo, Joanna Schmidt, et al.. (2019). Enhanced Potency of GalNAc-Conjugated Antisense Oligonucleotides in Hepatocellular Cancer Models. Molecular Therapy. 27(9). 1547–1557. 49 indexed citations

Zhou, Tianyuan, Joanna Schmidt, Youngsoo Kim, & A. Robert MacLeod. (2017). Therapeutic Targeting of Interferon Regulatory Factor 4 with Next Generation Antisense Oligonucleotides Produces Robust In Vivo Antitumor Activity in Preclinical Models of Multiple Myeloma. Blood. 130. 3078–3078. 3 indexed citations

Jo, Minji, Joanna Schmidt, Tianyuan Zhou, et al.. (2016). Strong pharmacological activity of locally administered next-generation antisense oligonucleotides (ASOs) in orthotopic lung cancer mouse models. Journal of Thoracic Oncology. 11(2). S26–S26. 1 indexed citations

Schmidt, Joanna, Minji Jo, Tianyuan Zhou, Youngsoo Kim, & A. Robert MacLeod. (2015). Abstract 4359: Characterization of GalNAc-conjugated generation 2.5 ASOs in DEN and DEN/CCL4-induced HCC tumors. Cancer Research. 75(15_Supplement). 4359–4359. 1 indexed citations

Kim, Youngsoo, Jeff Hsu, Tianyuan Zhou, et al.. (2013). Abstract LB-317: Potent in vivo pharmacology of AZD9150, a next-generation, constrained ethyl-modified antisense oligonucleotide targeting STAT3 in multiple preclinical cancer models.. Cancer Research. 73(8_Supplement). LB–317. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact